利用真实世界数据评估智能输液泵高危药品连续输注的滴定实践
本研究从美国20个卫生系统的Bainbridge Health输液泵网络提取2022年全年数据,分析347170次成人高危可滴定药物连续输注。结果显示1%的输注提示10倍剂量编程错误,1%超过建议最大剂量,9种药物中4种常滴定过快,提示需标准化滴定参数以优化药物库和剂量误差减少系统。
要点
- 智能输液泵剂量误差减少系统仍可能漏检编程错误和超最大剂量。
- 真实世界数据显示1%输注提示10倍剂量错误,1%超建议最大剂量。
- 9种高危药物中4种常被过快滴定,需建立标准化滴定参数。
核心结论
- 该数据分析识别出智能输液泵高危药品连续输注中的安全缺口,有助于建立更标准的滴定参数并优化药物库和剂量误差减少系统。
主要发现
- 1%的输注数据提示10倍剂量编程错误。
- 1%的输注超过建议最大剂量。
- 9种被审查药物中4种的输注常被滴定过快。
关键数值与推荐
- 审查的9种药物为右美托咪定、多巴酚丁胺、芬太尼、肝素、胰岛素、咪达唑仑、去甲肾上腺素、丙泊酚和血管加压素。
临床怎么用
- 临床可参考真实世界滴定数据识别高危药品连续输注的编程错误和超剂量风险,推动标准化滴定参数并优化智能泵药物库。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Smart infusion pumps provide dose error reduction systems (DERS) designed to intercept dosing and/or programming errors; however, DERS may not be able to capture all potential errors. Through analyzing the logged activity data of these devices, valuable insights for dose titration practices and risks during administration of high-alert continuous infusions can be determined. METHODS: Data were extracted from the Bainbridge Health Infusion Pump Network for the period of January through December 2022. Continuous infusions for adult patients of common, titratable, high-alert medications were selected. RESULTS: Data from the Bainbridge Health Infusion Pump Network, comprising 20 health systems across the US, yielded 347,170 infusions for analysis. The 9 medications identified for review were dexmedetomidine, dobutamine, fentanyl, heparin, insulin, midazolam, norepinephrine, propofol, and vasopressin. Data for 1% of infusions were suggestive of 10-fold dose programming errors, 1% of infusions exceeded suggested maximum doses, and infusions of 4 out of the 9 medications were often titrated too quickly. CONCLUSION: This first-of-its-kind data analysis identified safety gaps that can help establish greater standardization of appropriate titration parameters for high-alert medications. These standards can further optimize drug libraries and enhance DERS to increase medication safety in the use of smart infusion pumps.
引用
- Nery J, Jew R, Mandrack M, et al. Utilizing a real-world data set to assess titration practices for high-alert medications delivered via continuous infusions with smart infusion pumps. Am J Health Syst Pharm. 2026. PMID: 41240363. doi:10.1093/ajhp/zxaf297
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。